Health Canada has informed Canadians of a possible link between Baraclude [entecavir] and the development of a treatment-resistant HIV strain Media release 19 January 2013 Pages: 2 - 2
Patients receiving pharmacotherapies for attention-deficit hyperactivity disorder (ADHD) must be informed of potential cardiovascular and psychiatric adverse events Media release 19 January 2013 Pages: 2 - 2
GlaxoSmithKline has issued a ‘Dear Health Care Professional’ letter for Canada, outlining the increased rate of fractures in women receiving rosiglitazone-containing products News item 19 January 2013 Pages: 3 - 3
NVIC warns of HPV vaccine recombinant quadrivalent concerns Media release 19 January 2013 Pages: 3 - 3
Ranitidine appears to reduce the antiplatelet effect of aspirin Volunteers 19 January 2013 Pages: 5 - 5
Persistent postoperative neuropathy is a relatively rare complication Clinical study 19 January 2013 Pages: 5 - 5
Aspirin + anticoagulants increase risk of major haemorrhage Clinical study 19 January 2013 Pages: 5 - 5
GI disturbances are more common in women receiving tafenoquine Volunteers 19 January 2013 Pages: 5 - 5
